|1.||Stepniewska, K: 1 article (10/2006)|
|2.||Farrar, J J: 1 article (10/2006)|
|3.||Soni, N: 1 article (10/2006)|
|4.||Thwaites, G E: 1 article (10/2006)|
|5.||Thuy, T T D: 1 article (10/2006)|
|6.||Yen, L M: 1 article (10/2006)|
|7.||White, N J: 1 article (10/2006)|
|8.||Thwaites, C L: 1 article (10/2006)|
|9.||Loan, H T: 1 article (10/2006)|
|10.||Beltrão, Danielle: 1 article (08/2005)|
01/01/1980 - "Further studies are needed for the determination of the pathomechanism of bradycardia and to judge to what extent the inhalation anaesthetic agents influence the duration of action of pipecurium bromide."
04/01/1991 - "There were no incidences of significant bradycardia following pipecuronium administration. "
01/01/1980 - "Pipecurium bromide did not influence blood pressure but in contrast to the heart rate increasing effect of pancuronium bromide, it caused mild bradycardia. "
03/01/1989 - "Pancuronium but not pipecuronium or vecuronium, produced a significant degree of antagonism to the bradycardia produced by acetylcholine."
|2.||Cardiovascular Diseases (Cardiovascular Disease)
07/01/1995 - "Because of the low total plasma clearance in infants, pipecuronium dosage should be carefully monitored to avoid accumulation and prolonged paralysis."
02/01/1998 - "To test the hypothesis that acetylcholine "spillover" from motor nerves contributes significantly to skeletal muscle vasodilation during exercise, we measured the forearm blood flow responses during attempted handgripping after local paralysis of the forearm with the neuromuscular-blocking drug pipecuronium. "
02/01/2000 - "Also, lithium chloride was found to be capable of enhancing the paralysis of the indirectly stimulated rat diaphragm in vitro and gastrocnemius muscle in vivo induced by either pipecuronium or succinylcholine. "
10/01/1997 - "Propofol emulsion was found to be capable of enhancing the paralysis of the indirectly stimulated rat diaphragm in vitro and gastrocnemius muscle in vivo induced by either pipecuronium or succinylcholine. "
12/01/1989 - "We conclude that there is no clinical indication that the dosage of atracurium and vecuronium during inhalation anesthesia should be reduced, but the doses of pipecuronium and pancuronium should be reduced when prolonged paralysis is not desired."
|4.||Renal Insufficiency (Renal Failure)
|5.||Ganglion Cysts (Ganglion)
01/01/1980 - "Higher doses (1-2 mg/kg) cause transient decrease in blood pressure, in 10-20 mg/kg doses pipecurium bromide has ganglion blocking effect. "
05/01/1979 - "RGH 1106 doses not possess cardiotropic m-cholinolytic action, does not exert a ganglion blocking effect, nor affects the central nervous system. "
|2.||Vecuronium Bromide (Vecuronium)
|3.||Succinylcholine (Suxamethonium Chloride)
|5.||Acetylcholine (Acetylcholine Chloride)
|8.||Tubocurarine (Tubocurarine Chloride)
|9.||Nitrous Oxide (Laughing Gas)
|10.||Neuromuscular Blocking Agents